Amylyx Pharmaceuticals, Inc. - Common Stock (NQ: AMLX )
1.970
+0.040
(+2.07%)
Streaming Delayed Price
Updated: 1:28 PM EDT, Jun 28, 2024
Add to My Watchlist
All News about Amylyx Pharmaceuticals, Inc. - Common Stock
![](https://mms.businesswire.com/media/20230307005368/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/14/bull-g80539cf5f_1920.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230207005048/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4883.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230202005258/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://www.investors.com/wp-content/uploads/2021/03/FAB-inflation-040521-adobe.jpg)
![](https://mms.businesswire.com/media/20221122005013/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://www.investors.com/wp-content/uploads/2022/11/Stock-neurologybrain-02-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20221110006026/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
Amylyx Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 10, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221103005256/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://www.investors.com/wp-content/uploads/2021/07/Stock-Cytokinetics-01-shutt.jpg)
![](https://mms.businesswire.com/media/20221011005927/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20221006006078/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20221004006112/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
Amylyx Pharmaceuticals Announces Launch of Public Offering
October 04, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/10/04/screenshot_2022-10-04_at_5.38.23_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/02/biotech13.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/03/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/30/image-carnival_0.png?width=1200&height=800&fit=crop)
![](https://cms.zerohedge.com/s3/files/inline-images/ES%202022-09-30_7-58-08.jpg?itok=0R1EWRL8)
![](https://investorplace.com/wp-content/uploads/2021/12/quantum-computing-ionq-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600b.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/30/image42.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220929005962/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://www.investors.com/wp-content/uploads/2021/04/TECH1-drugs-041221-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2022/02/Stock-biohavenpharma-01-adobe.jpg)
![](https://mms.businesswire.com/media/20220914005209/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220912005236/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.